Liu D G, Zheng D N, Zhao Y N, Zhang Y Q, Ye X, Zhang L Q, Xie X Y, Zhang L, Zhang Z Y, Yu G Y
Department of Oral and Maxillofacial Radiology, Peking University School and Hospital of Stomatology & National Center of Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices & Beijing Key Laboratory of Digital Stomatology & NHC Research Center of Engineering and Technology for Computerized Dentistry & NMPA Key Laboratory for Dental Materials, Beijing 100081, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Feb 18;55(1):8-12. doi: 10.19723/j.issn.1671-167X.2023.01.002.
Sialolithiasis occurs in approximately 0.45% to 1.20% of the general population. The typical clinical symptom manifests as a painful swelling of the affected glands after a meal or upon salivary stimulation, which extremely affects the life quality of the patients. With the development of sialendoscopy and lithotripsy, most sialoliths can be successfully removed with preservation of the gland. However, sialoliths in the deep hilar-parenchymal submandibular ducts and impacted parotid stones located in the proximal ducts continue to pose great challenges. Our research center for salivary gland diseases (in Peking University School and Hospital of Stomatology) has used sialendoscopy for 17 years and treated >2 000 patients with salivary gland calculi. The success rate was approximately 92% for submandibular gland calculi and 95% for parotid calculi. A variety of minimally invasive surgical techniques have been applied and developed, which add substantial improvements in the treatment of refractory sialolithiasis. Further, the radiographic positioning criteria and treatment strategy are proposed for these intractable stones. Most of the hilar-parenchymal submandibular stones are successfully removed by a transoral approach, including transoral duct slitting and intraductal basket grasping, while a small portion of superficial stones can be removed by a mini-incision in submandibular area. Impacted stones located in the distal third of parotid gland ducts are removed "peri-ostium incision", which is applied to avoid a cicatricial stenosis from a direct ostium incision. Impacted parotid stones located in the middle and proximal third of the Stensen's duct are removed a direct mini-incision or a peri-auricular flap. A direct transcutaneous mini-incision is commonly performed under local anesthesia with an imperceptible scar, and is indicated for most of impacted stones located in the middle third, hilum and intraglandular ducts. By contrast, a peri-auricular flap is performed under general anesthesia with relatively larger operational injury of the gland parenchyma, and should be best reserved for deeper intraglandular stones. Laser lithotripsy has been applied in the treatment of sialolithiasis in the past decade, and holmium ∶YAG laser is reported to have the best therapeutic effects. During the past 3 years, our research group has performed laser lithotripsy for a few cases with intractable salivary stones. From our experiences, withdrawal of the endoscopic tip 0.5-1.0 cm away from the extremity of the laser fiber, consistent saline irrigation, and careful monitoring of gland swelling are of vital importance for avoidance of injuries of the ductal wall and the vulnerable endoscope lens during lithotripsy. Larger calculi require multiple treatment procedures. The risk of ductal stenosis can be alleviated by endoscopic dilation. In summary, appropriate use of various endoscopy-assisted lithotomy helps preserve the gland function in most of the patients with refractory sialolithiasis. Further studies are needed in the following aspects: Transcervical removal of intraglandular submandibular stones, intraductal laser lithotripsy of impacted parotid stones and deep submandibular stones, evaluation of long-term postoperative function of the affected gland, .
涎石病在普通人群中的发病率约为0.45%至1.20%。典型的临床症状表现为进食后或唾液受到刺激时患腺出现疼痛性肿胀,这极大地影响了患者的生活质量。随着涎腺内镜检查和碎石术的发展,大多数涎石能够在保留腺体的情况下成功取出。然而,下颌下腺深叶门部实质内导管的涎石以及位于腮腺导管近端的嵌顿性腮腺结石仍然是巨大的挑战。我们(北京大学口腔医学院口腔医院涎腺疾病研究中心)使用涎腺内镜已有17年,治疗了2000多名涎腺结石患者。下颌下腺结石的成功率约为92%,腮腺结石的成功率约为95%。已经应用并开发了多种微创手术技术,这在难治性涎石病的治疗方面有了显著改善。此外,还针对这些难治性结石提出了影像学定位标准和治疗策略。大多数下颌下腺门部实质内结石通过经口途径成功取出,包括经口导管切开和导管内篮式抓取,而一小部分表浅结石可通过下颌下区小切口取出。位于腮腺导管远侧三分之一的嵌顿性结石通过“骨膜切开术”取出,采用该方法可避免直接开口切开导致的瘢痕性狭窄。位于腮腺导管中三分之一和近三分之一的嵌顿性腮腺结石通过直接小切口或耳周皮瓣取出。直接经皮小切口通常在局部麻醉下进行,瘢痕不易察觉,适用于大多数位于中三分之一、门部和腺体内导管的嵌顿性结石。相比之下,耳周皮瓣手术在全身麻醉下进行,对腺实质的手术损伤相对较大,最好用于更深的腺体内结石。在过去十年中,激光碎石术已应用于涎石病的治疗,据报道钬∶YAG激光具有最佳治疗效果。在过去3年中,我们的研究小组对少数难治性涎腺结石病例进行了激光碎石术。根据我们的经验,在内镜尖端距激光纤维末端0.5 - 1.0 cm处撤离、持续生理盐水冲洗以及仔细监测腺体肿胀对于在碎石过程中避免导管壁和易损的内镜镜头受损至关重要。较大的结石需要多次治疗。内镜扩张可减轻导管狭窄的风险。总之,适当使用各种内镜辅助取石术有助于在大多数难治性涎石病患者中保留腺体功能。在以下方面还需要进一步研究:经颈取出下颌下腺腺体内结石、对嵌顿性腮腺结石和下颌下腺深部结石进行导管内激光碎石术、评估患腺术后的长期功能等。